127 related articles for article (PubMed ID: 38788394)
1. Sarmentol H derived from Sedum sarmentosum Bunge directly targets FXR to mitigate cholestasis by recruiting SRC-1.
Liu Z; Chen L; Chen M; Linghu L; Liao Z; Chen M; Wang G
Phytomedicine; 2024 Jul; 130():155759. PubMed ID: 38788394
[TBL] [Abstract][Full Text] [Related]
2. Yangonin protects against cholestasis and hepatotoxity via activation of farnesoid X receptor in vivo and in vitro.
Gao X; Fu T; Wang C; Ning C; Liu K; Liu Z; Sun H; Ma X; Huo X; Yang X; Zou M; Meng Q
Toxicol Appl Pharmacol; 2018 Jun; 348():105-116. PubMed ID: 29660435
[TBL] [Abstract][Full Text] [Related]
3. Picroside II protects against cholestatic liver injury possibly through activation of farnesoid X receptor.
Li T; Xu L; Zheng R; Wang X; Li L; Ji H; Hu Q
Phytomedicine; 2020 Mar; 68():153153. PubMed ID: 32018210
[TBL] [Abstract][Full Text] [Related]
4. Hesperidin alleviates cholestasis via activation of the farnesoid X receptor in vitro and in vivo.
Zhang G; Sun X; Wen Y; Shi A; Zhang J; Wei Y; Wu X
Eur J Pharmacol; 2020 Oct; 885():173498. PubMed ID: 32841642
[TBL] [Abstract][Full Text] [Related]
5. Effects of Sedi Herba (Sedum sarmentosum) on attenuating cholestasis by the activation of the farnesoid x receptor (FXR)-mediated signaling.
Liu Z; Liu D; Chen M; Zong W; Zhou X; Meng F; Jiang Y; Chen M; Liao Z; Wang G
Biomed Pharmacother; 2022 Nov; 155():113803. PubMed ID: 36271579
[TBL] [Abstract][Full Text] [Related]
6. Dehydrodiconiferyl alcohol, a lignan from Herpetospermum pedunculosum, alleviates cholestasis by activating pathways associated with the farnesoid X receptor.
Wei X; Ma Y; Dong Z; Wang G; Lan X; Liao Z; Chen M
Phytomedicine; 2021 Jan; 80():153378. PubMed ID: 33113499
[TBL] [Abstract][Full Text] [Related]
7. Wedelolactone alleviates cholestatic liver injury by regulating FXR-bile acid-NF-κB/NRF2 axis to reduce bile acid accumulation and its subsequent inflammation and oxidative stress.
Wang MQ; Zhang KH; Liu FL; Zhou R; Zeng Y; Chen AL; Yu Y; Xia Q; Zhu CC; Lin CZ
Phytomedicine; 2024 Jan; 122():155124. PubMed ID: 38014837
[TBL] [Abstract][Full Text] [Related]
8. JiaGaSongTang improves chronic cholestasis via enhancing FXR-mediated bile acid metabolism.
He X; Zhou Y; Yu J; Huang Q; Chen Z; Xiao R; Liu C; Gui S; Xiong T
Phytomedicine; 2024 Jun; 128():155347. PubMed ID: 38493717
[TBL] [Abstract][Full Text] [Related]
9. Picroside II alleviates liver injury induced by alpha-naphthylisothiocyanate through AMPK-FXR pathway.
Li T; Zheng R; Xu L; Zhou M; Wang X; Guo Q; Ji H; Li L
Toxicol Appl Pharmacol; 2020 Dec; 408():115248. PubMed ID: 32976922
[TBL] [Abstract][Full Text] [Related]
10. Network pharmacology-based mechanism prediction and pharmacological validation of Xiaoyan Lidan formula on attenuating alpha-naphthylisothiocyanate induced cholestatic hepatic injury in rats.
Wang M; Liu F; Yao Y; Zhang Q; Lu Z; Zhang R; Liu C; Lin C; Zhu C
J Ethnopharmacol; 2021 Apr; 270():113816. PubMed ID: 33444723
[TBL] [Abstract][Full Text] [Related]
11. Oleanolic acid alleviates ANIT-induced cholestatic liver injury by activating Fxr and Nrf2 pathways to ameliorate disordered bile acids homeostasis.
Liu J; Liu J; Meng C; Huang C; Liu F; Xia C
Phytomedicine; 2022 Jul; 102():154173. PubMed ID: 35605478
[TBL] [Abstract][Full Text] [Related]
12. Computational discovery and experimental verification of farnesoid X receptor agonist auraptene to protect against cholestatic liver injury.
Gao X; Fu T; Wang C; Ning C; Kong Y; Liu Z; Sun H; Ma X; Liu K; Meng Q
Biochem Pharmacol; 2017 Dec; 146():127-138. PubMed ID: 28987596
[TBL] [Abstract][Full Text] [Related]
13. 7, 8-Dihydroxy-4-methyl coumarin alleviates cholestasis via activation of the Farnesoid X receptor in vitro and in vivo.
Refat M; Zhang G; Ahmed A Saad A; Baldi S; Zheng F; Wu X
Chem Biol Interact; 2023 Jan; 370():110331. PubMed ID: 36581201
[TBL] [Abstract][Full Text] [Related]
14. Alisol B 23-acetate protects against ANIT-induced hepatotoxity and cholestasis, due to FXR-mediated regulation of transporters and enzymes involved in bile acid homeostasis.
Meng Q; Chen XL; Wang CY; Liu Q; Sun HJ; Sun PY; Huo XK; Liu ZH; Yao JH; Liu KX
Toxicol Appl Pharmacol; 2015 Mar; 283(3):178-86. PubMed ID: 25655198
[TBL] [Abstract][Full Text] [Related]
15. Opposite effects of the FXR agonist obeticholic acid on Mafg and Nrf2 mediate the development of acute liver injury in rodent models of cholestasis.
Carino A; Biagioli M; Marchianò S; Fiorucci C; Bordoni M; Roselli R; Di Giorgio C; Baldoni M; Ricci P; Monti MC; Morretta E; Zampella A; Distrutti E; Fiorucci S
Biochim Biophys Acta Mol Cell Biol Lipids; 2020 Sep; 1865(9):158733. PubMed ID: 32371093
[TBL] [Abstract][Full Text] [Related]
16. FXR-dependent Rubicon induction impairs autophagy in models of human cholestasis.
Panzitt K; Jungwirth E; Krones E; Lee JM; Pollheimer M; Thallinger GG; Kolb-Lenz D; Xiao R; Thorell A; Trauner M; Fickert P; Marschall HU; Moore DD; Wagner M
J Hepatol; 2020 Jun; 72(6):1122-1131. PubMed ID: 32001325
[TBL] [Abstract][Full Text] [Related]
17. NRF2 and FXR dual signaling pathways cooperatively regulate the effects of oleanolic acid on cholestatic liver injury.
Liu J; Liu J; Meng C; Gu Q; Huang C; Liu F; Xia C
Phytomedicine; 2023 Jan; 108():154529. PubMed ID: 36343550
[TBL] [Abstract][Full Text] [Related]
18. Dolomiaea souliei ethyl acetate extract protected against α-naphthylisothiocyanate-induced acute intrahepatic cholestasis through regulation of farnesoid x receptor-mediated bile acid metabolism.
Meng F; Zong W; Wei X; Tao Y; Wang G; Liao Z; Chen M
Phytomedicine; 2021 Jul; 87():153588. PubMed ID: 34091148
[TBL] [Abstract][Full Text] [Related]
19. SUMOylation of the farnesoid X receptor (FXR) regulates the expression of FXR target genes.
Balasubramaniyan N; Luo Y; Sun AQ; Suchy FJ
J Biol Chem; 2013 May; 288(19):13850-62. PubMed ID: 23546875
[TBL] [Abstract][Full Text] [Related]
20. Potential therapeutic action of tauroursodeoxycholic acid against cholestatic liver injury via hepatic Fxr/Nrf2 and CHOP-DR5-caspase-8 pathway.
Song G; Weng F; Zou B; Zhao J; Jin J; Yan D; Huang K; Sun X; Liu C; Hu Y; Li Y; Qiu F
Clin Sci (Lond); 2023 Apr; 137(7):561-577. PubMed ID: 36795945
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]